Includes bibliographical references (43 leaves) This study shows that when LR3IGF-I is administered to animals in pharmacologically active doses, it may be present in either the free form or bound to IGF-binding protein(s) in the circulation. Age and nutrition which are factors that regulate synthesis of endogenous IGF-I and IGF-binding proteins, affect the in vivo formation of complexes between the analog and IGFBP(s). This study also suggests that IGFBP-1 inhibits the pharmacological activity of circulating LR3IGF-I on thymus whereas it appears to stimulate the pharmacological activity of LR3IGF-I in kidneys.
Identifer | oai:union.ndltd.org:ADTP/79344 |
Date | January 1997 |
Creators | Gajanandana, Oraprapai. |
Source Sets | Australiasian Digital Theses Program |
Language | English |
Detected Language | English |
Relation | SUA |
Page generated in 0.0014 seconds